View all cases
UPC APP 33094/2025
- Case details
- Status—ActionProcedural applicationCategoryCase management orders
- Parties
- Claimants—Representatives
- Markus van Gardingen
Respondents- Moderna, Inc.Operating co.
- ModernaTX, Inc.Operating co.
- Moderna Belgium S.R.L.Operating co.
- Moderna Denmark ApSOperating co.
- Moderna Sweden ABOperating co.
- Moderna Switzerland GmbHOperating co.
- Moderna Portugal Unipessoal LDAOperating co.
- Moderna Norway ASOperating co.
- Moderna Poland Sp. z o.o.Operating co.
- Moderna Netherlands B.V.Operating co.
- Moderna Biotech UK LimitedOperating co.
- Moderna Germany GmbHOperating co.
- Moderna Biotech Spain SLOperating co.
- Moderna Italy S.R.L.Operating co.
- Moderna France SASUOperating co.
Representatives- Ruben Laddé
- Joachim Renken
- Division
- The Hague LD
- Language
- —
- First decided
- Aug 18, 2025
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| The Hague LD | Locked |
| Judge Samuel Granata | Locked |
| Judge András Kupecz | Locked |
| Judge Daniel Voss | Locked |
At the UPC: Moderna Group (20 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
Decisions
- 2025-08-18Application RoP 333Public
Summary: The Hague Local Division (18 August 2025) confirmed the preliminary objection order upholding UPC jurisdiction over multiple Moderna entities (including Moderna Spain and Moderna Norway) in infringement actions concerning COVID-19 vaccine Spikevax. The panel dismissed all Moderna's grounds challenging international jurisdiction under Brussels Regulation Art. 7(2) and 8(1) and the Lugano Convention.
Show the legal issues (4)
- Preliminary objection (R. 19 RoP)
- International jurisdiction (Art. 7(2) and 8(1) Brussels Regulation)
- Lugano Convention jurisdiction
- R. 333 review of preliminary objection order
Documents
- 5DF6AAC0842B4B9DEB69E14626FCE7BE_en.pdf2025-08-18EN